Tags

Type your tag names separated by a space and hit enter

[Subclinical thyroid disorders].
Pol Merkur Lekarski 2006; 21(126):573-8PM

Abstract

The term subclinical thyroid disorders apply to patients who have an abnormal serum thyroid-stimulating hormone (TSH) concentration but thyroxine and triiodothyronine levels within their reference ranges. Subclinical hypothyroidism occurs in 4% to 10% of the general population, and is especially prevalent in elderly women. Depending on the study, subclinical hyperthyroidism has been found in 0.6-16 % of the population. Potential risks of subclinical hypothyroidism include progression to overt hypothyroidism, dyslipidemia, cardiovascular complications, and neurological and neuropsychiatric effects. In turn, subclinical hyperthyroidism represents a considerable risk factor for atrial fibrillation in the elderly and for postmenopausal osteoporosis. Treatment of subclinical thyroid disorders is controversial. In this paper, we discuss the prevalence, aetiology, clinical presentation, diagnosis, natural history, and potential pathophysiological consequences of subclinical hypothyroidism and subclinical hyperthyroidism. We also provide some screening and management recommendations.

Authors+Show Affiliations

Department of Clinical Pharmacology, Silesian Medical University, Poland. r.krysiak@pharmanet.com.plNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

pol

PubMed ID

17405301

Citation

Krysiak, Robert, et al. "[Subclinical Thyroid Disorders]." Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego, vol. 21, no. 126, 2006, pp. 573-8.
Krysiak R, Okopień B, Herman ZS. [Subclinical thyroid disorders]. Pol Merkur Lekarski. 2006;21(126):573-8.
Krysiak, R., Okopień, B., & Herman, Z. S. (2006). [Subclinical thyroid disorders]. Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego, 21(126), pp. 573-8.
Krysiak R, Okopień B, Herman ZS. [Subclinical Thyroid Disorders]. Pol Merkur Lekarski. 2006;21(126):573-8. PubMed PMID: 17405301.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Subclinical thyroid disorders]. AU - Krysiak,Robert, AU - Okopień,Bogusław, AU - Herman,Zbigniew Stanisław, PY - 2007/4/5/pubmed PY - 2007/6/6/medline PY - 2007/4/5/entrez SP - 573 EP - 8 JF - Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego JO - Pol. Merkur. Lekarski VL - 21 IS - 126 N2 - The term subclinical thyroid disorders apply to patients who have an abnormal serum thyroid-stimulating hormone (TSH) concentration but thyroxine and triiodothyronine levels within their reference ranges. Subclinical hypothyroidism occurs in 4% to 10% of the general population, and is especially prevalent in elderly women. Depending on the study, subclinical hyperthyroidism has been found in 0.6-16 % of the population. Potential risks of subclinical hypothyroidism include progression to overt hypothyroidism, dyslipidemia, cardiovascular complications, and neurological and neuropsychiatric effects. In turn, subclinical hyperthyroidism represents a considerable risk factor for atrial fibrillation in the elderly and for postmenopausal osteoporosis. Treatment of subclinical thyroid disorders is controversial. In this paper, we discuss the prevalence, aetiology, clinical presentation, diagnosis, natural history, and potential pathophysiological consequences of subclinical hypothyroidism and subclinical hyperthyroidism. We also provide some screening and management recommendations. SN - 1426-9686 UR - https://www.unboundmedicine.com/medline/citation/17405301/[Subclinical_thyroid_disorders]_ L2 - https://medlineplus.gov/hyperthyroidism.html DB - PRIME DP - Unbound Medicine ER -